I do agree. Close to 100 million shares to be dumped. Can easily start another business elsewhere. No competitive advantages n low entry barriers. Thinking that winning some awards will make a difference.

This post has been edited by cckkpr: Jun 6 2023, 10:42 AM

He’s a doctor. Not only smart in studies but also try to make a quick kill.

I just listen to the MD briefing in highlights. 13 branches so far. Revenue for 2022 52 million. GP was 30% n PAT 20%. Revenue double from 2021 to 2022 due to double No of outlets. Another 10 to open in 2023 of which 2 already opened.
I think 2023 will still grow but whether at the 2022 growth rates as most hot areas already open clinics.
Low entry barriers. Business model similar to eye specialists whose main income is cataract operations while this is mainly skin care.
Ko skin clinics has the same services n was very aggressive in early days but now seems to hv slowed down.
Low IPO price. Good for a fast buck, provided good over subscription rate or else susah la.

Growth momentum shd be sustainable for 2023 due to opening of new outlets. Thereafter questionable as most targeted areas for outlets hv been opened. Many clients r first timer n repeated clients are not that many.
For hair issues, Yun Nam dominates the market n skin problems you need to see a dermatologist. Remembering Svenson n Marie France?

Latest qtr result not good. EPS for qtr only .3 sen. Projected eps for year only 1.2 sen